Survival and Prognostic Factors in Patients With Ovarian Cancer
暂无分享,去创建一个
T. Halvorsen | B. Hagen | F. Skjeldestad | S. Tingulstad | Solveig Tingulstad | Bjørn Hagen | Finn Egil Skjeldestad | Tore B Halvorsen
[1] T. Bjørge,et al. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993 , 1998, International journal of cancer.
[2] V. Torri,et al. Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG)). , 1990, British Journal of Cancer.
[3] K. Bertelsen. Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study. , 1990, Gynecologic oncology.
[4] F. Montz,et al. Inability of polyglycolic acid mesh to inhibit immediate post-radical pelvic surgery adhesions. , 1990, Gynecologic oncology.
[5] R. Rosenfeld,et al. Validation of the Charlson Comorbidity Index in Patients With Head and Neck Cancer: A Multi‐institutional Study , 1997, The Laryngoscope.
[6] L. Mcgowan. Epidemiology of ovarian cancer. , 1989, Oncology.
[7] T. Halvorsen,et al. Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway , 2002, International journal of cancer.
[8] C. Gillis,et al. Management of ovarian cancer: referral to a multidisciplinary team matters. , 1994, British Journal of Cancer.
[9] D. Fortune. Histological Typing of Ovarian Tumours , 1975 .
[10] G. Fleuren,et al. Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors , 1987, Cancer.
[11] J. Spinelli,et al. Ovarian Carcinoma: A Multivariate Analysis of Prognostic Factors , 1985, Obstetrics and gynecology.
[12] H. Stalsberg,et al. Observer variation in histologic classification of malignant and borderline ovarian tumors. , 1988, Human pathology.
[13] J. Neijt,et al. A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectives. , 1989, European journal of cancer & clinical oncology.
[14] U. Menon. Ovarian cancer screening , 2002, Canadian Medical Association Journal.
[15] A. Heintz,et al. Cytoreductive surgery in ovarian carcinoma: Feasibility and morbidity , 1986 .
[16] D.,et al. Regression Models and Life-Tables , 2022 .
[17] J. Carstensen,et al. Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer. , 1993, Gynecologic oncology.
[18] M. Gore,et al. Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner? , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] G. Chêne,et al. Long-term results and prognostic factors in patients with epithelial ovarian cancer. , 2000, Gynecologic oncology.
[20] N. Breslow,et al. Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.
[21] T. Bjørge,et al. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954‐1993 , 1997, International journal of cancer.
[22] B. Lund,et al. Original article: Prognostic factors for overall survival in patients with advanced ovarian carcinoma , 1991 .
[23] B. Lund,et al. Prognostic factors for overall survival in patients with advanced ovarian carcinoma. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] A. Talerman,et al. The prognostic variability of ovarian tumor grading by different pathologists. , 1987, Gynecologic oncology.
[25] D G Altman,et al. A prognostic model for ovarian cancer , 2001, British Journal of Cancer.
[26] G. Lyman,et al. Comorbidity and functional status are independent in older cancer patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] K. Nustad,et al. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. , 1999, Obstetrics and gynecology.
[28] C. Griffiths. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. , 1975, National Cancer Institute monograph.
[29] J. Berek,et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. , 1994, American journal of obstetrics and gynecology.
[30] R. Elashoff,et al. Primary Cytoreductive Surgery for Epithelial Ovarian Cancer , 1983, Obstetrics and gynecology.
[31] L. Melton,et al. Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary. , 1984, American journal of obstetrics and gynecology.
[32] R. Scully. Histological Typing of Ovarian Tumours , 1999, World Health Organization. International Histological Classification of Tumours.
[33] E. Trimble,et al. Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis. , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] Griffiths Ct. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. , 1975 .
[35] Steven J Skates,et al. Screening for ovarian cancer: a pilot randomised controlled trial , 1999, The Lancet.
[36] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[37] C. la Vecchia,et al. Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry, Switzerland. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.